14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Dec 22, 2021 $31.17 $31.99 $30.50 $31.07 1 042 455
Dec 21, 2021 $31.17 $32.14 $30.97 $31.14 1 431 399
Dec 20, 2021 $29.98 $32.08 $29.50 $31.26 2 409 164
Dec 17, 2021 $27.47 $30.80 $26.86 $30.55 3 575 289
Dec 16, 2021 $28.20 $28.99 $27.22 $27.65 2 308 346
Dec 15, 2021 $26.50 $28.36 $26.06 $28.20 6 418 035
Dec 14, 2021 $25.51 $26.99 $24.61 $24.90 11 929 202
Dec 13, 2021 $26.08 $32.49 $24.71 $29.06 5 241 025
Dec 10, 2021 $29.09 $29.28 $27.35 $27.59 1 095 038
Dec 09, 2021 $30.09 $30.67 $28.89 $28.95 599 546
Dec 08, 2021 $29.87 $30.92 $29.20 $30.39 876 795
Dec 07, 2021 $29.77 $30.60 $29.17 $29.62 1 346 102
Dec 06, 2021 $27.55 $28.77 $26.86 $28.17 775 965
Dec 03, 2021 $28.98 $29.13 $27.23 $27.46 993 105
Dec 02, 2021 $27.21 $28.97 $26.92 $28.91 1 149 939
Dec 01, 2021 $28.26 $28.87 $27.12 $27.13 1 129 850
Nov 30, 2021 $27.90 $28.99 $27.30 $28.26 990 627
Nov 29, 2021 $29.78 $29.79 $27.75 $27.98 1 796 128
Nov 26, 2021 $29.96 $30.40 $28.70 $29.25 643 758
Nov 24, 2021 $29.80 $30.42 $29.21 $30.29 551 966
Nov 23, 2021 $30.26 $30.62 $29.50 $30.03 893 716
Nov 22, 2021 $31.89 $31.89 $29.76 $30.35 1 172 052
Nov 19, 2021 $32.15 $32.60 $31.28 $31.41 590 930
Nov 18, 2021 $33.27 $33.62 $31.86 $32.47 909 177
Nov 17, 2021 $33.42 $33.46 $32.45 $32.97 796 241
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT